+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
ID03667417

Study of BRCA Gene Mutation Carriers to Track Breast and Ovarian Cancer Risks A 10-Year Prospective Observational Study

Led by Institut Paoli-Calmettes · Updated on 2026-10-14

5000

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research focuses on individuals who carry a BRCA gene mutation, which increases the genetic risk for breast and ovarian cancers. The study aims to observe the incidence of these cancers over a long period, helping to understand the impact of carrying these mutations. Participants include both women and men, with or without existing cancer diagnoses at the start of the study. Participants in this observational study will undergo standardized data collection through questionnaires and will be followed prospectively for 10 years. No experimental treatments are administered instead, the study collects information to monitor health outcomes related to the BRCA gene mutation. During the study, participants will provide data through questionnaires and regular follow-up assessments over the 10-year period. Researchers will measure the occurrence of breast and ovarian cancers during this time. The study includes safety monitoring and long-term observation to better understand cancer risks associated with BRCA mutations.

CONDITIONS

Brief Title

Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation

Research Team

D

Dominique GENRE, MD

M

Margot BERLINE, MSc, MBA

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here